Chronic Heart Failure Clinical Trial
Official title:
Effect of an Eccentrically Biased Aerobic Exercise Program on Quality of Life and Functional Capacity in People With Chronic Heart Failure: A Randomized Controlled Trial.
Verified date | February 2020 |
Source | La Trobe University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Many studies have shown that exercise training is beneficial for patients with chronic heart
failure (CHF). Heart Foundation guidelines strongly recommend regular physical activity and
referral to a specifically designed rehabilitation program for all patients with CHF who are
medically stable. Such programs usually comprise aerobic exercises such as walking, and light
weightlifting with care to avoid heavy straining due to stress that this may place on the
heart.
Eccentric contractions are those in which the muscle lengthens as it contracts. Exercise
involving eccentric contractions is known to increase muscle strength and this type of
exercise also requires less oxygen. This is because it requires less power to resist lowering
a weight than it does to lift a weight. Initial evidence suggests that this form of exercise
has favourable outcomes in the frail elderly and those with chronic disease.
This study aims to determine if eccentric exercise can be applied to patients with heart
failure to increase their physical function while using less energy so that exercise is more
tolerable for patients who complain of significant breathlessness and fatigue. This study
also aims to determine if eccentric exercise is a safe alternative exercise option for
patients at risk of negative events.
The investigators propose to run a randomised controlled trial. Eccentric exercise will be
delivered to a group of heart failure patients referred to the existing heart failure
rehabilitation program at the Northern Hospital. The program will consist of eight weeks of
twice weekly exercise of one hour's duration comprising eccentric exercise combined with
walking and light weight training. This will be compared to a group of patients participating
in the current exercise program consisting of light weightlifting and aerobic exercises for
the same length and duration of exercise and also to a third group of patients who will be
wait listed for 8 weeks. Following the completion of the eight week waiting period, these
patients will be offered the option of joining the standard exercise program.
The investigators expect that the eccentric exercise group will have improved walking
capacity and quality of life compared with the traditional program and the wait-list control
group. It is also possible that there is no difference between the eccentric and traditional
program in terms of functional outcomes but that the participants report that eccentric
exercise is easier.
Status | Completed |
Enrollment | 47 |
Est. completion date | March 2019 |
Est. primary completion date | March 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - aged > 18 years - a clinical diagnosis of heart failure either systolic or diastolic on transthoracic echocardiogram - mild to moderate heart failure - medically stable heart failure - have received approval when assessed by the group physiotherapist to participate in the exercise program as is usual practice. Where concerns arise during assessment, clearance will be sought from the treating cardiologist. Exclusion Criteria: - hospitalisation for a CHF exacerbation within the previous month - severe heart failure classified as level four on the New York heart association classification (short of breath at rest) - unstable medical condition such as uncontrolled angina, diabetes or hypertension - dementia or a psychological disorder that would interfere with participation in group exercise - participation in a cardiac or heart failure rehabilitation program in the prior six months - contraindications to exercise (ie aneurysm, valvular disease) - the presence of any pre-existing neurological or musculoskeletal condition, for example stroke, that on assessment is deemed to interfere with exercise participation. |
Country | Name | City | State |
---|---|---|---|
Australia | The Northern Hospital | Epping | Victoria |
Lead Sponsor | Collaborator |
---|---|
La Trobe University | Northern Hospital, Australia |
Australia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Fatigue as measured by participant questionnaire | post 8-week exercise program and 3-month follow-up | ||
Other | lower limb strength as measured as a one-repetition maximum leg press | post 8-week exercise program and 3-month follow-up | ||
Primary | functional improvement measured by change in six-minute walk distance | post 8-week exercise program and 3-month follow-up | ||
Secondary | Quality of life measured by participant questionnaire | post 8-week exercise program and 3-month follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03597646 -
The Effect of Kinesio Taping on Pulmonary Function and Functional Capacity in Patients With Chronic Heart Failure
|
N/A | |
Terminated |
NCT04065997 -
Apogee International
|
||
Withdrawn |
NCT03675113 -
Effect of Upper Extremity Aerobic Exercise Training on Exercise Capacity Patients With Chronic Heart Failure
|
N/A | |
Completed |
NCT02916160 -
Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study
|
Phase 4 | |
Completed |
NCT03126656 -
Effects of Testosterone on Myocardial Repolarization
|
Phase 4 | |
Completed |
NCT02247245 -
The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients.
|
N/A | |
Completed |
NCT02268500 -
VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT)
|
Phase 4 | |
Terminated |
NCT01906957 -
Cognition and Exercise Training
|
N/A | |
Completed |
NCT01919918 -
Muscle Afferent Feedback Effects in Patients With Heart Failure
|
Phase 1 | |
Not yet recruiting |
NCT01669395 -
Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial
|
N/A | |
Completed |
NCT00984529 -
Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia
|
N/A | |
Recruiting |
NCT00863421 -
Sleep Disordered Breathing in Patients With Chronic Heart Failure
|
N/A | |
Completed |
NCT02840565 -
Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453
|
Phase 1 | |
Completed |
NCT02441218 -
Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study
|
Phase 3 | |
Completed |
NCT00149409 -
Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure
|
Phase 2/Phase 3 | |
Terminated |
NCT05532046 -
A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT)
|
Phase 1 | |
Recruiting |
NCT04984928 -
Readmission Risk of Patients With Heart Failure.
|
||
Completed |
NCT02814097 -
A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction
|
Phase 2 | |
Active, not recruiting |
NCT05560737 -
ODYSSEE-vCHAT Mental Health Program for Heart Failure and Kidney Disease Patients
|
||
Recruiting |
NCT03286127 -
Palliative Outcome Evaluation Muenster I
|